BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31700260)

  • 1. Ginsenoside Rg3 and Korean Red Ginseng extract epigenetically regulate the tumor-related long noncoding RNAs RFX3-AS1 and STXBP5-AS1.
    Ham J; Jeong D; Park S; Kim HW; Kim H; Kim SJ
    J Ginseng Res; 2019 Oct; 43(4):625-634. PubMed ID: 31700260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation.
    Park JE; Kim HW; Yun SH; Kim SJ
    J Ginseng Res; 2021 Nov; 45(6):754-762. PubMed ID: 34764730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rh2 Suppresses Breast Cancer Cell Proliferation by Epigenetically Regulating the Long Noncoding RNA C3orf67-AS1.
    Jeong D; Ham J; Park S; Kim HW; Kim H; Ji HW; Kim SJ
    Am J Chin Med; 2019; 47(7):1643-1658. PubMed ID: 31645124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-Wide Methylation Analysis Identifies NOX4 and KDM5A as Key Regulators in Inhibiting Breast Cancer Cell Proliferation by Ginsenoside Rg3.
    Ham J; Lee S; Lee H; Jeong D; Park S; Kim SJ
    Am J Chin Med; 2018; 46(6):1333-1355. PubMed ID: 30149757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA STXBP5-AS1 suppresses stem cell-like properties of pancreatic cancer by epigenetically inhibiting neighboring androglobin gene expression.
    Chen S; Huang L; Li G; Qiu F; Wang Y; Yang C; Pan J; Wu Z; Chen J; Tian Y
    Clin Epigenetics; 2020 Nov; 12(1):168. PubMed ID: 33160411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rg3 Prevents Oncogenic Long Noncoding RNA ATXN8OS from Inhibiting Tumor-Suppressive microRNA-424-5p in Breast Cancer Cells.
    Kim H; Ji HW; Kim HW; Yun SH; Park JE; Kim SJ
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33477683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA STXBP5-AS1 inhibits cell proliferation, migration, and invasion via preventing the PI3K/AKT against STXBP5 expression in non-small-cell lung carcinoma.
    Huang J; Xie N; Huang H; Yao J; Hu W
    J Cell Biochem; 2019 May; 120(5):7489-7498. PubMed ID: 30450569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA STXBP5-AS1 inhibits cell proliferation, migration, and invasion through inhibiting the PI3K/AKT signaling pathway in gastric cancer cells.
    Cen D; Huang H; Yang L; Guo K; Zhang J
    Onco Targets Ther; 2019; 12():1929-1936. PubMed ID: 30881044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The standardized Korean Red Ginseng extract and its ingredient ginsenoside Rg3 inhibit manifestation of breast cancer stem cell-like properties through modulation of self-renewal signaling.
    Oh J; Yoon HJ; Jang JH; Kim DH; Surh YJ
    J Ginseng Res; 2019 Jul; 43(3):421-430. PubMed ID: 31308814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Korean red ginseng extract prevents APAP-induced hepatotoxicity through metabolic enzyme regulation: the role of ginsenoside Rg3, a protopanaxadiol.
    Gum SI; Cho MK
    Liver Int; 2013 Aug; 33(7):1071-84. PubMed ID: 23750847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivity-guided isolation of ginsenosides from Korean Red Ginseng with cytotoxic activity against human lung adenocarcinoma cells.
    Yu JS; Roh HS; Baek KH; Lee S; Kim S; So HM; Moon E; Pang C; Jang TS; Kim KH
    J Ginseng Res; 2018 Oct; 42(4):562-570. PubMed ID: 30337817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Korean Red Ginseng and Rg3 on Asian Sand Dust-Induced MUC5AC, MUC5B, and MUC8 Expression in Bronchial Epithelial Cells.
    Shin SH; Ye MK; Lee DW; Kang BJ; Chae MH
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33916022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.
    Shao S; Wang C; Wang S; Zhang H; Zhang Y
    Biomed Pharmacother; 2019 Sep; 117():109082. PubMed ID: 31212131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
    Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Korean Red Ginseng on metabolic syndrome.
    Yoon SJ; Kim SK; Lee NY; Choi YR; Kim HS; Gupta H; Youn GS; Sung H; Shin MJ; Suk KT
    J Ginseng Res; 2021 May; 45(3):380-389. PubMed ID: 34025131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rg3-enriched Korean Red Ginseng enhances blood pressure stability in spontaneously hypertensive rats.
    Nagar H; Choi S; Jung SB; Jeon BH; Kim CS
    Integr Med Res; 2016 Sep; 5(3):223-229. PubMed ID: 28462122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng.
    Mochizuki M; Yoo YC; Matsuzawa K; Sato K; Saiki I; Tono-oka S; Samukawa K; Azuma I
    Biol Pharm Bull; 1995 Sep; 18(9):1197-202. PubMed ID: 8845804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rg3-enriched red ginseng extract promotes lung cancer cell apoptosis and mitophagy by ROS production.
    Hwang SK; Jeong YJ; Cho HJ; Park YY; Song KH; Chang YC
    J Ginseng Res; 2022 Jan; 46(1):138-146. PubMed ID: 35058730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and
    Jeong D; Irfan M; Kim SD; Kim S; Oh JH; Park CK; Kim HK; Rhee MH
    J Ginseng Res; 2017 Oct; 41(4):548-555. PubMed ID: 29021703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rg3 suppresses ovarian cancer cell proliferation and invasion by inhibiting the expression of lncRNA H19.
    Zhao L; Sun W; Zheng A; Zhang Y; Fang C; Zhang P
    Acta Biochim Pol; 2021 May; 68(4):575-582. PubMed ID: 34038042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.